Fem-Dophilus® features two patented, clinically-validated probiotic strains – GR-1® and RC-14® – discovered and developed by esteemed scientists Dr. Gregor Reid and Dr. Andrew Bruce of Urex Biotech. This innovative blend has been studied for 25+ years, showing impactful results for helping to restore and maintain vaginal and urinary tract health.* A unique manufacturing process helps ensure these probiotic powerhouses make it safely to the lower intestine, promoting their full effectiveness.*
GR-1®/RC-14® and VAGINAL FLORA (also called microbiota)

In one of the randomized clinical trials, 75% of women in the GR-1®/RC-14® probiotic group experienced significant improvement in vaginal flora composition, while only 34% of women in the placebo (non-probiotic) group experienced similar improvement.

Martinez, et al. Can J Microbiol 2009;55:133-138